Metraipolis › archive › dc_de53c7439cee

Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer — Europe PMC PMID:42102812

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42102812
DOI
10.1016/j.ccell.2026.04.005
License (as archived)
solo-consultazione
Archived
2026-10-07T22:58:11.597Z
SHA-256 of the archived text
b6e8ceb718dd08355859503df350dc03f467e6ad28feff2aeed55f60828b95ad
Stable URL of this page
https://metraipolis.com/documento/dc_de53c7439cee

How to cite

Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer — Europe PMC PMID:42102812 — Europe PMC (en), https://europepmc.org/article/MED/42102812 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de53c7439cee (Metraipolis archive dc_de53c7439cee, sha256 b6e8ceb718dd08355859503df350dc03f467e6ad28feff2aeed55f60828b95ad)
BibTeX
@misc{dcde53c7439cee,
  title = {Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer — Europe PMC PMID:42102812},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42102812},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de53c7439cee; sha256 b6e8ceb718dd08355859503df350dc03f467e6ad28feff2aeed55f60828b95ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42102812. Agents can read the archived copy with the MCP tool read_document.